{"disease":{"id":"chronic-graft-versus-host-disease-chronic-gvhd","name":"chronic graft versus host disease chronic gvhd"},"drugs":{"marketed":[{"drug_id":"belumosudil","indication_name":"Chronic graft-versus-host disease (chronic GVHD)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Rezurock","generic_name":"BELUMOSUDIL","company_name":"Kadmon Pharms Llc","drug_phase":"marketed","molecular_target":"Rho-associated protein kinase 1","drug_class":"","quality_score":55,"revenue":null,"mechanism":"Rezurock works by inhibiting the Rho-associated protein kinase 1 enzyme, which plays a key role in inflammation and immune response."}],"pipeline":[],"offLabel":[],"totalMarketed":1,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT02611180","title":"Dendritic Cells in Patients With Acute or Chronic Skin Graft Versus Host Disease","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":22,"lead_sponsor_name":"Washington University School of Medicine","has_results":false},{"nct_id":"NCT06458127","title":"Tele-Palliative Care Intervention for Patients With Chronic Graft-Versus-Host Disease","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":10,"lead_sponsor_name":"Massachusetts General Hospital","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}